436 related articles for article (PubMed ID: 12101276)
21. Activation of murine macrophages by Neisseria meningitidis and IFN-gamma in vitro: distinct roles of class A scavenger and Toll-like pattern recognition receptors in selective modulation of surface phenotype.
Mukhopadhyay S; Peiser L; Gordon S
J Leukoc Biol; 2004 Sep; 76(3):577-84. PubMed ID: 15218052
[TBL] [Abstract][Full Text] [Related]
22. Capsaicin inhibits IFN-gamma-induced MHC class II expression by suppressing transcription of class II transactivator gene in murine peritoneal macrophages.
Mahmoud ME; Nikami H; Shiina T; Takewaki T; Shimizu Y
Int Immunopharmacol; 2010 Jan; 10(1):86-90. PubMed ID: 19825429
[TBL] [Abstract][Full Text] [Related]
23. Revisiting the specificity of the MHC class II transactivator CIITA in vivo.
Otten LA; Leibundgut-Landmann S; Huarte J; Kos-Braun IC; Lavanchy C; Barras E; Borisch B; Steimle V; Acha-Orbea H; Reith W
Eur J Immunol; 2006 Jun; 36(6):1548-58. PubMed ID: 16703565
[TBL] [Abstract][Full Text] [Related]
24. Class II MHC gene expression in microglia. Regulation by the cytokines IFN-gamma, TNF-alpha, and TGF-beta.
Panek RB; Benveniste EN
J Immunol; 1995 Mar; 154(6):2846-54. PubMed ID: 7876554
[TBL] [Abstract][Full Text] [Related]
25. Differential regulation of class II MHC determinants on macrophages by IFN-gamma and IL-4.
Cao H; Wolff RG; Meltzer MS; Crawford RM
J Immunol; 1989 Dec; 143(11):3524-31. PubMed ID: 2479682
[TBL] [Abstract][Full Text] [Related]
26. Class II transactivator and class II MHC gene expression in microglia: modulation by the cytokines TGF-beta, IL-4, IL-13 and IL-10.
O'Keefe GM; Nguyen VT; Benveniste EN
Eur J Immunol; 1999 Apr; 29(4):1275-85. PubMed ID: 10229095
[TBL] [Abstract][Full Text] [Related]
27. Mycoplasma fermentans-derived lipid inhibits class II major histocompatibility complex expression without mediation by interleukin-6, interleukin-10, tumor necrosis factor, transforming growth factor-beta, type I interferon, prostaglandins or nitric oxide.
Frisch M; Gradehandt G; Mühlradt PF
Eur J Immunol; 1996 May; 26(5):1050-7. PubMed ID: 8647166
[TBL] [Abstract][Full Text] [Related]
28. Presentation of exogenous antigens by macrophages: analysis of major histocompatibility complex class I and II presentation and regulation by cytokines.
Kovacsovics-Bankowski M; Rock KL
Eur J Immunol; 1994 Oct; 24(10):2421-8. PubMed ID: 7925570
[TBL] [Abstract][Full Text] [Related]
29. IFN gamma/TNF alpha synergism in MHC class II induction: effect of nicotinamide on MHC class II expression but not on islet-cell apoptosis.
Kim KA; Kim S; Chang I; Kim GS; Min YK; Lee MK; Kim KW; Lee MS
Diabetologia; 2002 Mar; 45(3):385-93. PubMed ID: 11914744
[TBL] [Abstract][Full Text] [Related]
30. Two T cell epitopes from the M5 protein of viable Streptococcus pyogenes engage different pathways of bacterial antigen processing in mouse macrophages.
Delvig AA; Robinson JH
J Immunol; 1998 Jun; 160(11):5267-72. PubMed ID: 9605123
[TBL] [Abstract][Full Text] [Related]
31. Augmentation or inhibition of IFN-gamma-induced MHC class II expression by lipopolysaccharides. The roles of TNF-alpha and nitric oxide, and the importance of the sequence of signaling.
Sicher SC; Chung GW; Vazquez MA; Lu CY
J Immunol; 1995 Dec; 155(12):5826-34. PubMed ID: 7499872
[TBL] [Abstract][Full Text] [Related]
32. Selective antigen presenting activity of cortical thymic epithelial cells against CD4+ T cells associated with both lack of costimulatory molecules and inefficient presentation of MHC-peptide ligands.
Kaneda R; Iwabuchi K; Kasai M; Murakami M; Uede T; Onoé K
Cell Immunol; 1997 Nov; 181(2):163-71. PubMed ID: 9398403
[TBL] [Abstract][Full Text] [Related]
33. Collagen and major histocompatibility class II expression in mesenchymal cells from CIITA hypomorphic mice.
Xu Y; McDonald J; Perloff E; Butticè G; Schreiber BM; Smith BD
Mol Immunol; 2007 Mar; 44(7):1709-21. PubMed ID: 16982097
[TBL] [Abstract][Full Text] [Related]
34. Tumor cells transduced with the MHC class II Transactivator and CD80 activate tumor-specific CD4+ T cells whether or not they are silenced for invariant chain.
Thompson JA; Dissanayake SK; Ksander BR; Knutson KL; Disis ML; Ostrand-Rosenberg S
Cancer Res; 2006 Jan; 66(2):1147-54. PubMed ID: 16424052
[TBL] [Abstract][Full Text] [Related]
35. A CIITA-independent pathway that promotes expression of endogenous rather than exogenous peptides in immune-privileged sites.
Arancibia-Cárcamo CV; Osawa H; Arnett HA; Háskova Z; George AJ; Ono SJ; Ting JP; Streilein JW
Eur J Immunol; 2004 Feb; 34(2):471-80. PubMed ID: 14768052
[TBL] [Abstract][Full Text] [Related]
36. Transforming growth factor-beta released by PPD-presenting malignant mesothelioma cells inhibits interferon-gamma synthesis by an anti-PPD CD4+ T-cell clone.
Valle MT; Porta C; Megiovanni AM; Libener R; Mele L; Gaudino G; Strizzi L; Guida R; Toma S; Mutti L
Int J Mol Med; 2003 Feb; 11(2):161-7. PubMed ID: 12525871
[TBL] [Abstract][Full Text] [Related]
37. Immune selection in murine tumors. Ph.d thesis.
Svane IM; Engel AM
APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
[TBL] [Abstract][Full Text] [Related]
38. Interferon-gamma mediates antigen trafficking to MHC class II-positive late endosomes of enterocytes.
Büning J; Schmitz M; Repenning B; Ludwig D; Schmidt MA; Strobel S; Zimmer KP
Eur J Immunol; 2005 Mar; 35(3):831-42. PubMed ID: 15688349
[TBL] [Abstract][Full Text] [Related]
39. TGF-beta suppression of IFN-gamma-induced class II MHC gene expression does not involve inhibition of phosphorylation of JAK1, JAK2, or signal transducers and activators of transcription, or modification of IFN-gamma enhanced factor X expression.
Panek RB; Lee YJ; Benveniste EN
J Immunol; 1995 Jan; 154(2):610-9. PubMed ID: 7814871
[TBL] [Abstract][Full Text] [Related]
40. Astrocytes express elements of the class II endocytic pathway and process central nervous system autoantigen for presentation to encephalitogenic T cells.
Soos JM; Morrow J; Ashley TA; Szente BE; Bikoff EK; Zamvil SS
J Immunol; 1998 Dec; 161(11):5959-66. PubMed ID: 9834077
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
